Skip to main content
. 2018 Jan 12;57(8):1001–1015. doi: 10.1007/s40262-017-0607-4

Fig. 4.

Fig. 4

Proposed main metabolic pathways of vilaprisan in humans. AKR aldoketoreductase, CYP cytochrome P450, VPR vilaprisan